AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots
Executive Summary
AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising
You may also be interested in...
AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall
An AstraZeneca study on consumer communication through direct-to-consumer television advertisements identifies five risks as the optimal number to include in order to ensure consumer recall of safety information
AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall
An AstraZeneca study on consumer communication through direct-to-consumer television advertisements identifies five risks as the optimal number to include in order to ensure consumer recall of safety information
Merck DTC Research Tool Under Development With Input From FDA
Merck is developing a research protocol to evaluate consumer understanding of direct-to-consumer television ads for prescription drugs, the company announced